Product Details

Verdob is a sterile, pyrogen-free injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Dobutamine Hydrochloride at 12.5mg/mL for intravenous use in the management of cardiac decompensation. As a result, it offers a fast-acting inotropic agent for critical care and cardiac support settings.

The injection contains:

• Dobutamine Hydrochloride IP (equivalent to Dobutamine 12.5mg per mL) – A direct-acting beta-1 adrenergic receptor agonist that increases myocardial contractility. Consequently, it improves cardiac output and stroke volume with comparatively modest effects on heart rate.

Intensivists and cardiologists use Verdob for the short-term treatment of cardiac decompensation caused by depressed contractility, whether from organic heart disease or cardiac surgical procedures. In addition, its rapid onset and titratable action allow precise haemodynamic control during infusion. Because of this profile, Verdob suits ICUs, cardiac care units, and operating theatres where inotropic support is essential.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the sterile, pyrogen-free formulation supports safe IV infusion
• Furthermore, each single-dose vial delivers precise, validated dosage accuracy at 12.5mg/mL
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected vial packaging preserves product stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, ICUs, and cardiac care units